5.2M
XNAS Volume
High volume+loss today
XNAS 17 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Sheila A Denton | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.06 per share. | 04 Mar 2025 | 599 | 26,447 (0%) | 0% | 58.1 | 34,778 | Common Stock |
Sheila A Denton | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 599 | 18,552 | - | - | Employee Stock Option (right to buy) | |
Sheila A Denton | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 69.99 per share. | 04 Mar 2025 | 599 | 25,848 (0%) | 0% | 70.0 | 41,924 | Common Stock |
Sheila A Denton | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 9,574 | 19,151 | - | - | Employee Stock Option (right to buy) | |
Sheila A Denton | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 74.08 per share. | 26 Feb 2025 | 4,495 | 25,848 (0%) | 0% | 74.1 | 332,990 | Common Stock |
Sheila A Denton | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 74.07 per share. | 26 Feb 2025 | 9,574 | 30,343 (0%) | 0% | 74.1 | 709,146 | Common Stock |
Sheila A Denton | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.06 per share. | 26 Feb 2025 | 9,574 | 39,917 (0%) | 0% | 58.1 | 555,866 | Common Stock |
Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,552 | 81,515 (0%) | 0% | 0 | Common Stock | |
Lee Heeson | EVP, Head of Incyte Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 6,331 | 32,778 (0%) | 0% | 0 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.47 per share. | 21 Jan 2025 | 429 | 70,963 (0%) | 0% | 73.5 | 31,519 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 14,772 | 14,772 | - | - | Employee Stock Option (right to buy) | |
Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 40,289 | 40,289 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,516 | 25,516 | - | - | Employee Stock Option (right to buy) | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 55,510 | 55,510 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 20,144 | 20,144 | - | - | Employee Stock Option (right to buy) | |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 14,772 | 14,772 | - | - | Employee Stock Option (right to buy) | |
Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.69 per share. | 17 Jan 2025 | 12,352 | 66,967 (0%) | 0% | 72.7 | 897,867 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,202 | 28,202 | - | - | Employee Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 3,432 | 3,432 | - | - | Employee Stock Option (right to buy) | |
Sheila A Denton | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 12,086 | 12,086 | - | - | Employee Stock Option (right to buy) | |
Matteo Trotta | EVP, GM, Dermatology US | 17 Jan 2025 | 5,371 | 5,371 | - | - | Employee Stock Option (right to buy) | ||
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 3,672 | 91,525 (0%) | 0% | 72.5 | 266,073 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 3,158 | 53,374 (0%) | 0% | 72.5 | 228,829 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 10,692 | 79,319 (0%) | 0% | 72.5 | 774,742 | Common Stock |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 908 | 71,392 (0%) | 0% | 72.5 | 65,794 | Common Stock |
Mohamed Khairie Issa | EVP, Head of US Oncology | 06 Jan 2025 | 48,671 | 48,671 (0%) | 0% | 0 | Common Stock | ||
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 69.07 per share. | 31 Dec 2024 | 331 | 19,713 (0%) | 0% | 69.1 | 22,862 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 69.07 per share. | 31 Dec 2024 | 339 | 17,071 (0%) | 0% | 69.1 | 23,415 | Common Stock |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 69.31 per share. | 13 Dec 2024 | 650 | 23,312 (0%) | 0% | 69.3 | 45,052 | Common Stock |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 70.64 per share. | 13 Dec 2024 | 650 | 23,962 (0%) | 0% | 70.6 | 45,916 | Common Stock |
Paula J. Swain | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. | 09 Dec 2024 | 873 | 85,203 (0%) | 0% | 72.1 | 62,952 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. | 09 Dec 2024 | 1,510 | 56,532 (0%) | 0% | 72.1 | 108,886 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 75.37 per share. | 29 Nov 2024 | 5,683 | 30,658 (0%) | 0% | 75.4 | 428,328 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 75.60 per share. | 29 Nov 2024 | 360 | 36,341 (0%) | 0% | 75.6 | 27,216 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.27 per share. | 06 Nov 2024 | 1,424 | 59,466 (0%) | 0% | 72.3 | 102,912 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 2,256 | 0 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 1,424 | 0 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 78.21 per share. | 06 Nov 2024 | 2,256 | 58,042 (0%) | 0% | 78.2 | 176,442 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 82.00 per share. | 06 Nov 2024 | 1,424 | 60,298 (0%) | 0% | 82 | 116,768 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 06 Nov 2024 | 2,256 | 61,722 (0%) | 0% | 68.6 | 154,807 | Common Stock |
Sheila A Denton | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.63 per share. | 02 Oct 2024 | 2,136 | 30,343 (0%) | 0% | 67.6 | 144,458 | Common Stock |
Lee Heeson | EVP, Head of Incyte Intl | 01 Oct 2024 | 26,447 | 26,447 (0%) | 0% | 0 | Common Stock | ||
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 66.10 per share. | 30 Sep 2024 | 368 | 19,382 (0%) | 0% | 66.1 | 24,325 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 66.10 per share. | 30 Sep 2024 | 378 | 16,732 (0%) | 0% | 66.1 | 24,986 | Common Stock |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 12 Sep 2024 | 7,333 | 36,390 (0%) | 0% | 62.4 | 457,359 | Common Stock | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 12 Sep 2024 | 1,117 | 43,723 (0%) | 0% | 62.3 | 69,589 | Common Stock | |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 63.37 per share. | 12 Sep 2024 | 382 | 24,443 (0%) | 0% | 63.4 | 24,207 | Common Stock |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 62.94 per share. | 12 Sep 2024 | 572 | 24,825 (0%) | 0% | 62.9 | 36,002 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.63 per share. | 12 Aug 2024 | 11,608 | 90,011 (0%) | 0% | 60.6 | 703,793 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 25 Jul 2024 | 15,571 | 36,701 (0%) | 0% | 70 | 1,089,970 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 16,284 | 16,284 | - | - | Employee Stock Option (right to buy) | |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 7,278 | 86,625 (0%) | 0% | 0 | Common Stock | |
Paula J. Swain | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 549 | 86,076 (0%) | 0% | 64.2 | 35,273 | Common Stock |
Pablo J. Cagnoni | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 749 | 221,170 (0%) | 0% | 64.2 | 48,123 | Common Stock |
Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 19,851 | 221,919 (0%) | 0% | 0 | Common Stock | |
Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 44,411 | 44,411 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 12,572 | 96,145 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 28,127 | 28,127 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 948 | 95,197 (0%) | 0% | 64.3 | 60,909 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 4,961 | 496,674 (0%) | 0% | 64.2 | 318,744 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 41,025 | 501,635 (0%) | 0% | 0 | Common Stock | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 61,189 | 61,189 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 22,205 | 22,205 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 64.19 per share. | 15 Jul 2024 | 1,306 | 58,042 (0%) | 0% | 64.2 | 83,832 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 1,111 | 59,348 (0%) | 0% | 64.3 | 71,382 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 9,925 | 60,459 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP, GMAPPS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 549 | 52,272 (0%) | 0% | 64.2 | 35,273 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 16,284 | 16,284 | - | - | Employee Stock Option (right to buy) | |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 7,278 | 52,821 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 1,555 | 101,619 (0%) | 0% | 64.3 | 99,909 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 31,088 | 31,088 | - | - | Employee Stock Option (right to buy) | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 13,895 | 103,174 (0%) | 0% | 0 | Common Stock | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 3,783 | 3,783 | - | - | Employee Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 5,073 | 25,863 (0%) | 0% | 0 | Common Stock | |
Thomas Tray | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 466 | 25,397 (0%) | 0% | 64.3 | 29,941 | Common Stock |
Sheila A Denton | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 13,323 | 13,323 | - | - | Employee Stock Option (right to buy) | |
Sheila A Denton | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 5,955 | 32,479 (0%) | 0% | 0 | Common Stock | |
Matteo Trotta | EVP, GM, Dermatology US | 15 Jul 2024 | 5,921 | 5,921 | - | - | Employee Stock Option (right to buy) | ||
Matteo Trotta | EVP, GM, Dermatology US | 15 Jul 2024 | 2,646 | 10,474 (0%) | 0% | 0 | Common Stock | ||
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 09 Jul 2024 | 8,148 | 50,534 (0%) | 0% | 60 | 488,880 | Common Stock |
Paula J. Swain | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 5,560 | 79,347 (0%) | 0% | 59.0 | 328,151 | Common Stock |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 6,870 | 83,573 (0%) | 0% | 59.0 | 405,467 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 41,723 | 460,610 (0%) | 0% | 59.0 | 2,462,491 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 7,695 | 58,682 (0%) | 0% | 59.0 | 454,159 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 5,706 | 45,543 (0%) | 0% | 59.0 | 336,768 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 8,316 | 89,279 (0%) | 0% | 59.0 | 490,810 | Common Stock |
Thomas Tray | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 844 | 20,790 (0%) | 0% | 59.0 | 49,813 | Common Stock |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 60.62 per share. | 28 Jun 2024 | 399 | 19,014 (0%) | 0% | 60.6 | 24,187 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 60.62 per share. | 28 Jun 2024 | 409 | 16,354 (0%) | 0% | 60.6 | 24,794 | Common Stock |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,517 | 12,517 | - | - | Non Qualfied Stock Option (right to buy) | |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,830 | 18,323 (0%) | 0% | 0 | Common Stock | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,830 | 18,615 (0%) | 0% | 0 | Common Stock | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,517 | 12,517 | - | - | Non Qualfied Stock Option (right to buy) | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,517 | 12,517 | - | - | Non Qualfied Stock Option (right to buy) | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,830 | 16,808 (0%) | 0% | 0 | Common Stock | |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,830 | 8,734 (0%) | 0% | 0 | Common Stock | |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,517 | 12,517 | - | - | Non Qualfied Stock Option (right to buy) | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,830 | 15,945 (0%) | 0% | 0 | Common Stock | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,517 | 12,517 | - | - | Non Qualfied Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 12 Jun 2024 | 19,164 | 66,377 (0%) | 0% | 60 | 1,149,840 | Common Stock |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,517 | 12,517 | - | - | Non Qualfied Stock Option (right to buy) | |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,830 | 10,823 (0%) | 0% | 0 | Common Stock | |
Susanne Schaffert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,830 | 5,720 (0%) | 0% | 0 | Common Stock | |
Susanne Schaffert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,517 | 12,517 | - | - | Non Qualfied Stock Option (right to buy) | |
Susanne Schaffert | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.94 per share. | 12 Jun 2024 | 752 | 2,890 (0%) | 0% | 59.9 | 45,075 | Common Stock |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 58.91 per share. | 06 Jun 2024 | 1,093 | 21,634 (0%) | 0% | 58.9 | 64,389 | Common Stock |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 56.97 per share. | 28 Mar 2024 | 403 | 15,785 (0%) | 0% | 57.0 | 22,959 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 56.97 per share. | 28 Mar 2024 | 413 | 13,115 (0%) | 0% | 57.0 | 23,529 | Common Stock |
Matteo Trotta | EVP, GM, Dermatology US | 25 Mar 2024 | 21,868 | 21,868 | - | - | Employee Stock Option (right to buy) | ||
Matteo Trotta | EVP, GM, Dermatology US | 25 Mar 2024 | 7,828 | 7,828 (0%) | 0% | 0 | Common Stock | ||
Hoppenot Herve | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 41,577 | 502,333 (0%) | 0% | 0 | Common Stock | |
Stamoulis Christiana | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 89,983 (0%) | 0% | 0 | Common Stock | |
H. Steven Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 97,595 (0%) | 0% | 0 | Common Stock | |
Paula Swain J. | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 84,907 (0%) | 0% | 0 | Common Stock | |
P. Flannelly Barry | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 85,080 (0%) | 0% | 0 | Common Stock | |
Iyengar K. Vijay | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 50,789 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.84 per share. | 12 Feb 2024 | 387 | 82,606 (0%) | 0% | 57.8 | 22,384 | Common Stock |
Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.50 per share. | 22 Jan 2024 | 108 | 72,300 (0%) | 0% | 61.5 | 6,642 | Common Stock |
Elliott Dickinson Jonathan | EVP, General Manager, Europe | 22 Jan 2024 | 108 | 44,380 (0%) | 0% | 61.5 | 6,642 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 30,580 | 30,580 | - | - | Employee Stock Option (right to buy) | |
Michael Morrissey James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.49 per share. | 18 Jan 2024 | 122 | 72,408 (0%) | 0% | 61.5 | 7,502 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 16,018 | 16,018 | - | - | Employee Stock Option (right to buy) | |
Stamoulis Christiana | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 27,668 | 27,668 | - | - | Employee Stock Option (right to buy) | |
Elliott Dickinson Jonathan | EVP, General Manager, Europe | 18 Jan 2024 | 8,114 | 44,610 (0%) | 0% | 61.2 | 496,415 | Common Stock | |
Hoppenot Herve | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 97,566 | 97,566 | - | - | Employee Stock Option (right to buy) | |
Elliott Jonathan Dickinson | EVP, General Manager, Europe | 18 Jan 2024 | 122 | 44,488 (0%) | 0% | 61.5 | 7,502 | Common Stock | |
James Morrissey Michael | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 61.18 per share. | 18 Jan 2024 | 11,359 | 72,530 (0%) | 0% | 61.2 | 694,944 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 16,018 | 16,018 | - | - | Employee Stock Option (right to buy) | |
Flannelly Barry P. | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 21,843 | 21,843 | - | - | Employee Stock Option (right to buy) | |
Pablo Cagnoni J. | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 21,843 | 21,843 | - | - | Employee Stock Option (right to buy) | |
P. Flannelly Barry | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.48 per share. | 17 Jan 2024 | 3,675 | 77,703 (0%) | 0% | 61.5 | 225,939 | Common Stock |
Tray Thomas | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.48 per share. | 17 Jan 2024 | 1,021 | 22,415 (0%) | 0% | 61.5 | 62,771 | Common Stock |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 4,530 | 4,530 | - | - | Employee Stock Option (right to buy) | |
Jonathan Dickinson Elliott | EVP, General Manager, Europe | 16 Jan 2024 | 101 | 36,496 (0%) | 0% | 61.5 | 6,209 | Common Stock | |
Elliott Dickinson Jonathan | EVP, General Manager, Europe | 16 Jan 2024 | 101 | 36,597 (0%) | 0% | 61.3 | 6,195 | Common Stock | |
Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.48 per share. | 16 Jan 2024 | 101 | 61,171 (0%) | 0% | 61.5 | 6,209 | Common Stock |
Morrissey James Michael | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.34 per share. | 16 Jan 2024 | 101 | 61,272 (0%) | 0% | 61.3 | 6,195 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 65.51 per share. | 03 Jan 2024 | 7,365 | 90,218 (0%) | 0% | 65.5 | 482,481 | Common Stock |
Iyengar Vijay K. | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 02 Jan 2024 | 657 | 43,412 (0%) | 0% | 65 | 42,705 | Common Stock |
Clancy J. Paul | Director | Grant, award, or other acquisition of securities at price $ 62.79 per share. | 29 Dec 2023 | 412 | 15,382 (0%) | 0% | 62.8 | 25,869 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 62.79 per share. | 29 Dec 2023 | 423 | 12,702 (0%) | 0% | 62.8 | 26,560 | Common Stock |
Tray Thomas | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 57.36 per share. | 12 Dec 2023 | 210 | 24,503 (0%) | 0% | 57.4 | 12,046 | Common Stock |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 12 Dec 2023 | 1,067 | 23,436 (0%) | 0% | 62.4 | 66,549 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.28 per share. | 01 Aug 2023 | 21,511 | 97,583 (0%) | 0% | 63.3 | 1,361,216 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 14,868 | 14,868 | - | - | Employee Stock Option (right to buy) | |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 7,089 | 85,979 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 12,246 | 82,993 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 25,682 | 25,682 | - | - | Employee Stock Option (right to buy) | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 43,184 | 434,856 (0%) | 0% | 0 | Common Stock | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 90,563 | 90,563 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 20,275 | 20,275 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 9,668 | 81,378 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 14,868 | 14,868 | - | - | Employee Stock Option (right to buy) | |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 7,089 | 44,069 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 28,385 | 28,385 | - | - | Employee Stock Option (right to buy) | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 13,535 | 119,094 (0%) | 0% | 0 | Common Stock | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 9,668 | 69,724 (0%) | 0% | 0 | Common Stock | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 20,275 | 20,275 | - | - | Employee Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 8,056 | 58,968 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 16,896 | 16,896 | - | - | Employee Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 4,204 | 4,204 | - | - | Employee Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 6,015 | 24,539 (0%) | 0% | 0 | Common Stock | |
Paula J. Swain | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 5,783 | 78,890 (0%) | 0% | 62.1 | 359,009 | Common Stock |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 6,073 | 70,747 (0%) | 0% | 62.1 | 377,012 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 43,467 | 391,672 (0%) | 0% | 62.1 | 2,698,431 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 6,304 | 71,710 (0%) | 0% | 62.1 | 391,352 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 6,215 | 36,980 (0%) | 0% | 62.1 | 385,827 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 8,442 | 105,559 (0%) | 0% | 62.1 | 524,079 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 8,468 | 60,056 (0%) | 0% | 62.1 | 525,693 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 6,044 | 50,912 (0%) | 0% | 62.1 | 375,212 | Common Stock |
Thomas Tray | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 1,136 | 18,524 (0%) | 0% | 62.1 | 70,523 | Common Stock |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 62.25 per share. | 30 Jun 2023 | 380 | 14,591 (0%) | 0% | 62.3 | 23,655 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 62.25 per share. | 30 Jun 2023 | 390 | 11,890 (0%) | 0% | 62.3 | 24,278 | Common Stock |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,505 | 15,493 (0%) | 0% | 0 | Common Stock | |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,294 | 11,294 | - | - | Non-Qualified Stock Option (right to buy) | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,505 | 14,211 (0%) | 0% | 0 | Common Stock | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,294 | 11,294 | - | - | Non-Qualified Stock Option (right to buy) | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,505 | 13,978 (0%) | 0% | 0 | Common Stock | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,294 | 11,294 | - | - | Non-Qualified Stock Option (right to buy) | |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,294 | 11,294 | - | - | Non-Qualified Stock Option (right to buy) | |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,505 | 5,904 (0%) | 0% | 0 | Common Stock | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,505 | 11,500 (0%) | 0% | 0 | Common Stock | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,294 | 11,294 | - | - | Non-Qualified Stock Option (right to buy) | |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,294 | 11,294 | - | - | Non-Qualified Stock Option (right to buy) | |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,505 | 7,993 (0%) | 0% | 0 | Common Stock | |
Susanne Schaffert | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.44 per share. | 14 Jun 2023 | 488 | 3,642 (0%) | 0% | 61.4 | 29,983 | Common Stock |
Susanne Schaffert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,505 | 4,130 (0%) | 0% | 0 | Common Stock | |
Susanne Schaffert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,294 | 11,294 | - | - | Non-Qualified Stock Option (right to buy) | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 72.27 per share. | 31 Mar 2023 | 318 | 11,706 (0%) | 0% | 72.3 | 22,982 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 72.27 per share. | 31 Mar 2023 | 326 | 8,995 (0%) | 0% | 72.3 | 23,560 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,693 | 0 | - | - | Incentive Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.42 per share. | 16 Feb 2023 | 3,693 | 56,956 (0%) | 0% | 65.4 | 241,596 | Common Stock |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.08 per share. | 13 Feb 2023 | 848 | 76,791 (0%) | 0% | 80.1 | 67,908 | Common Stock |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.08 per share. | 13 Feb 2023 | 331 | 76,460 (0%) | 0% | 80.1 | 26,506 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 802 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.78 per share. | 31 Jan 2023 | 802 | 69,326 (0%) | 0% | 74.8 | 59,974 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 84.06 per share. | 31 Jan 2023 | 802 | 68,524 (0%) | 0% | 84.1 | 67,416 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 4,842 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 84.73 per share. | 30 Jan 2023 | 14,374 | 68,524 (0%) | 0% | 84.7 | 1,217,909 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.50 per share. | 30 Jan 2023 | 14,374 | 82,898 (0%) | 0% | 80.5 | 1,157,107 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 84.70 per share. | 30 Jan 2023 | 11,861 | 68,524 (0%) | 0% | 84.7 | 1,004,627 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.27 per share. | 30 Jan 2023 | 11,861 | 80,385 (0%) | 0% | 72.3 | 857,194 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 84.70 per share. | 30 Jan 2023 | 10,438 | 68,524 (0%) | 0% | 84.7 | 884,099 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 30 Jan 2023 | 10,438 | 78,962 (0%) | 0% | 68.6 | 716,256 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 84.69 per share. | 30 Jan 2023 | 12,865 | 68,524 (0%) | 0% | 84.7 | 1,089,537 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.36 per share. | 30 Jan 2023 | 12,865 | 81,389 (0%) | 0% | 65.4 | 840,856 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 5,644 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 14,374 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 11,861 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 10,438 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 12,865 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 84.73 per share. | 30 Jan 2023 | 4,842 | 68,524 (0%) | 0% | 84.7 | 410,263 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.78 per share. | 30 Jan 2023 | 4,842 | 73,366 (0%) | 0% | 74.8 | 362,085 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 85.07 per share. | 30 Jan 2023 | 5,644 | 68,524 (0%) | 0% | 85.1 | 480,135 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.58 per share. | 30 Jan 2023 | 5,644 | 74,168 (0%) | 0% | 83.6 | 471,726 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2023 | 7,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Vijay K. Iyengar | EVP, GMAPPS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 26 Jan 2023 | 7,000 | 49,835 (0%) | 0% | 68.6 | 480,340 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 26 Jan 2023 | 7,000 | 42,835 (0%) | 0% | 85 | 595,000 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 26 Jan 2023 | 2,419 | 53,263 (0%) | 0% | 85 | 205,615 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 84,673 (0%) | 0% | 0 | Common Stock | |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 14,194 | 14,194 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 77,639 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 24,515 | 24,515 | - | - | Employee Stock Option (right to buy) | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 29,196 | 435,139 (0%) | 0% | 0 | Common Stock | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 86,449 | 86,449 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 19,354 | 19,354 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 77,654 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 14,194 | 14,194 | - | - | Employee Stock Option (right to buy) | |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 42,835 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 114,001 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 27,096 | 27,096 | - | - | Employee Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 19,354 | 19,354 | - | - | Employee Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 68,524 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 55,682 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 16,128 | 16,128 | - | - | Employee Stock Option (right to buy) | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 20 Jan 2023 | 6,159 | 36,338 (0%) | 0% | 0 | Common Stock | ||
Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 6,159 | 61,373 (0%) | 0% | 0 | Common Stock | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 2,968 | 2,968 | - | - | Employee Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 2,833 | 19,439 (0%) | 0% | 0 | Common Stock | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 19 Jan 2023 | 105 | 30,179 (0%) | 0% | 83.9 | 8,807 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.88 per share. | 19 Jan 2023 | 105 | 55,214 (0%) | 0% | 83.9 | 8,807 | Common Stock |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 15 Jan 2023 | 87 | 30,284 (0%) | 0% | 81.3 | 7,070 | Common Stock | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 15 Jan 2023 | 87 | 30,371 (0%) | 0% | 81.3 | 7,070 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,319 (0%) | 0% | 81.3 | 7,070 | Common Stock |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,406 (0%) | 0% | 81.3 | 7,070 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 79.78 per share. | 04 Jan 2023 | 28,399 | 109,021 (0%) | 0% | 79.8 | 2,265,672 | Common Stock |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 04 Jan 2023 | 117 | 30,458 (0%) | 0% | 79.1 | 9,252 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.08 per share. | 04 Jan 2023 | 117 | 55,493 (0%) | 0% | 79.1 | 9,252 | Common Stock |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 80.32 per share. | 30 Dec 2022 | 294 | 11,388 (0%) | 0% | 80.3 | 23,614 | Common Stock |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 80.32 per share. | 30 Dec 2022 | 252 | 11,473 (0%) | 0% | 80.3 | 20,241 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 80.32 per share. | 30 Dec 2022 | 302 | 8,669 (0%) | 0% | 80.3 | 24,257 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 80.79 per share. | 23 Dec 2022 | 1,654 | 37,855 (0%) | 0% | 80.8 | 133,627 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 80.77 per share. | 23 Dec 2022 | 804 | 39,509 (0%) | 0% | 80.8 | 64,939 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 80.80 per share. | 23 Dec 2022 | 7,000 | 40,313 (0%) | 0% | 80.8 | 565,600 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 23 Dec 2022 | 7,000 | 47,313 (0%) | 0% | 68.6 | 480,340 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 80.80 per share. | 23 Dec 2022 | 7,866 | 40,313 (0%) | 0% | 80.8 | 635,573 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.86 per share. | 23 Dec 2022 | 7,866 | 48,179 (0%) | 0% | 72.9 | 573,117 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2022 | 7,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Vijay K. Iyengar | EVP, GMAPPS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2022 | 7,866 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 82.16 per share. | 19 Dec 2022 | 1,223 | 16,606 (0%) | 0% | 82.2 | 100,482 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.36 per share. | 12 Dec 2022 | 533 | 50,702 (0%) | 0% | 82.4 | 43,898 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 69.59 per share. | 19 Oct 2022 | 165 | 8,367 (0%) | 0% | 69.6 | 11,482 | Common Stock |
Susanne Schaffert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 1,625 | 1,625 (0%) | 0% | 0 | Common Stock | |
Susanne Schaffert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 6,751 | 6,751 | - | - | Non-Qualified Stock Option (right to buy) | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 66.64 per share. | 30 Sep 2022 | 339 | 11,094 (0%) | 0% | 66.6 | 22,591 | Common Stock |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 66.64 per share. | 30 Sep 2022 | 291 | 11,221 (0%) | 0% | 66.6 | 19,392 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 66.64 per share. | 30 Sep 2022 | 250 | 8,202 (0%) | 0% | 66.6 | 16,660 | Common Stock |
Thomas Tray | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 83.13 per share. | 22 Jul 2022 | 1,564 | 17,702 (0%) | 0% | 83.1 | 130,015 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 79.38 per share. | 07 Jul 2022 | 2,873 | 72,674 (0%) | 0% | 79.4 | 228,059 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 79.38 per share. | 07 Jul 2022 | 5,787 | 40,313 (0%) | 0% | 79.4 | 459,372 | Common Stock |
Paula J. Swain | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 2,599 | 79,693 (0%) | 0% | 79.3 | 205,971 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 9,921 | 82,292 (0%) | 0% | 0 | Common Stock | |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 13,443 | 13,443 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 1,124 | 72,659 (0%) | 0% | 79.3 | 89,077 | Common Stock |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 23,221 | 23,221 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 17,317 | 73,783 (0%) | 0% | 0 | Common Stock | |
Herve Hoppenot | Director, Chairman / CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 21,174 | 405,943 (0%) | 0% | 79.3 | 1,678,040 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 81,885 | 81,885 | - | - | Employee Stock Option (right to buy) | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 60,433 | 427,117 (0%) | 0% | 0 | Common Stock | |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 3,506 | 75,547 (0%) | 0% | 79.3 | 277,851 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 18,332 | 18,332 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 13,529 | 79,053 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 13,443 | 13,443 | - | - | Employee Stock Option (right to buy) | |
Vijay K. Iyengar | EVP, GMAPPS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 2,599 | 46,100 (0%) | 0% | 79.3 | 205,971 | Common Stock |
Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 9,921 | 48,699 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 3,856 | 137,420 (0%) | 0% | 79.3 | 305,588 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 18,941 | 141,276 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 25,665 | 25,665 | - | - | Employee Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 18,332 | 18,332 | - | - | Employee Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 3,043 | 63,544 (0%) | 0% | 79.3 | 241,158 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 13,529 | 66,587 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 11,274 | 53,416 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 2,181 | 51,235 (0%) | 0% | 79.2 | 172,844 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 15,277 | 15,277 | - | - | Employee Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 2,810 | 2,810 | - | - | Employee Stock Option (right to buy) | |
Thomas Tray | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 987 | 19,266 (0%) | 0% | 79.3 | 78,220 | Common Stock |
Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 4,149 | 20,253 (0%) | 0% | 0 | Common Stock | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 75.97 per share. | 30 Jun 2022 | 321 | 10,755 (0%) | 0% | 76.0 | 24,386 | Common Stock |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 75.97 per share. | 30 Jun 2022 | 275 | 10,930 (0%) | 0% | 76.0 | 20,892 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 75.97 per share. | 30 Jun 2022 | 236 | 7,952 (0%) | 0% | 76.0 | 17,929 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.63 per share. | 28 Jun 2022 | 11,488 | 122,335 (0%) | 0% | 75.6 | 868,837 | Common Stock |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,124 | 9,124 | - | - | Non-Qualified Stock Option (right to buy) | |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,144 | 12,988 (0%) | 0% | 0 | Common Stock | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,144 | 10,434 (0%) | 0% | 0 | Common Stock | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,124 | 9,124 | - | - | Non-Qualified Stock Option (right to buy) | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,124 | 9,124 | - | - | Non-Qualified Stock Option (right to buy) | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,144 | 10,655 (0%) | 0% | 0 | Common Stock | |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,124 | 9,124 | - | - | Non-Qualified Stock Option (right to buy) | |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,144 | 3,399 (0%) | 0% | 0 | Common Stock | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,124 | 9,124 | - | - | Non-Qualified Stock Option (right to buy) | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,144 | 7,716 (0%) | 0% | 0 | Common Stock | |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,144 | 5,488 (0%) | 0% | 0 | Common Stock | |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,124 | 9,124 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.95 per share. | 09 Apr 2022 | 517 | 53,058 (0%) | 0% | 80.9 | 41,851 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 82.96 per share. | 08 Apr 2022 | 1,248 | 65,163 (0%) | 0% | 83.0 | 103,534 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 82.96 per share. | 08 Apr 2022 | 881 | 66,411 (0%) | 0% | 83.0 | 73,088 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 08 Apr 2022 | 20,516 | 87,808 (0%) | 0% | 68.6 | 1,407,808 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.27 per share. | 08 Apr 2022 | 21,348 | 88,640 (0%) | 0% | 72.3 | 1,542,820 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 84.00 per share. | 08 Apr 2022 | 21,348 | 67,292 (0%) | 0% | 84 | 1,793,232 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 83.01 per share. | 08 Apr 2022 | 20,516 | 67,292 (0%) | 0% | 83.0 | 1,703,033 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 21,348 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 20,516 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 79.42 per share. | 31 Mar 2022 | 326 | 8,290 (0%) | 0% | 79.4 | 25,891 | Common Stock |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 79.42 per share. | 31 Mar 2022 | 249 | 17,768 (0%) | 0% | 79.4 | 19,776 | Common Stock |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 79.42 per share. | 31 Mar 2022 | 280 | 8,511 (0%) | 0% | 79.4 | 22,238 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 79.42 per share. | 31 Mar 2022 | 240 | 5,572 (0%) | 0% | 79.4 | 19,061 | Common Stock |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 11 Feb 2022 | 846 | 56,616 (0%) | 0% | 66.8 | 56,479 | Common Stock |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 11 Feb 2022 | 331 | 56,285 (0%) | 0% | 66.8 | 22,098 | Common Stock |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 31 Jan 2022 | 7,375 | 30,214 (0%) | 0% | 74.2 | 547,151 | Common Stock | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 24 Jan 2022 | 78 | 37,589 (0%) | 0% | 75.3 | 5,877 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.35 per share. | 24 Jan 2022 | 78 | 55,610 (0%) | 0% | 75.3 | 5,877 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 84,852 | 84,852 | - | - | Employee Stock Option (right to buy) | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Paul Trower | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 3,250 | 3,250 | - | - | Employee Stock Option (right to buy) | |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 18 Jan 2022 | 101 | 30,708 (0%) | 0% | 75.0 | 7,576 | Common Stock | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 18 Jan 2022 | 6,959 | 37,667 (0%) | 0% | 0 | Common Stock | ||
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 18 Jan 2022 | 101 | 30,809 (0%) | 0% | 75.0 | 7,576 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.01 per share. | 18 Jan 2022 | 101 | 48,830 (0%) | 0% | 75.0 | 7,576 | Common Stock |
Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 6,959 | 55,688 (0%) | 0% | 0 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.01 per share. | 18 Jan 2022 | 101 | 48,729 (0%) | 0% | 75.0 | 7,576 | Common Stock |
Paula J. Swain | EVP, Human Resources | Sale of securities on an exchange or to another person at price $ 73.31 per share. | 07 Jan 2022 | 10,870 | 72,371 (0%) | 0% | 73.3 | 796,880 | Common Stock |
Paula J. Swain | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 10,870 | 0 | - | - | Non Qualfied Stock Option (right to buy) | |
Paula J. Swain | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 07 Jan 2022 | 10,870 | 83,241 (0%) | 0% | 73.2 | 795,793 | Common Stock |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 04 Jan 2022 | 136 | 30,910 (0%) | 0% | 71.8 | 9,766 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.81 per share. | 04 Jan 2022 | 136 | 48,931 (0%) | 0% | 71.8 | 9,766 | Common Stock |
Paul Trower | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 03 Jan 2022 | 6,818 | 39,086 (0%) | 0% | 73.2 | 499,146 | Common Stock |
Paul Trower | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 1,396 | 0 | - | - | Incentive Stock Option (right to buy) | |
Paul Trower | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 6,818 | 0 | - | - | Non- Qualified Stock Option (right to buy) | |
Paul Trower | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 73.31 per share. | 03 Jan 2022 | 1,396 | 32,268 (0%) | 0% | 73.3 | 102,341 | Common Stock |
Paul Trower | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 03 Jan 2022 | 1,396 | 33,664 (0%) | 0% | 73.2 | 102,201 | Common Stock |
Paul Trower | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 73.31 per share. | 03 Jan 2022 | 6,818 | 32,268 (0%) | 0% | 73.3 | 499,828 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 8,678 | 72,371 (0%) | 0% | 0 | Common Stock | |
Paula J. Swain | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 01 Jan 2022 | 9,319 | 81,690 (0%) | 0% | 73.2 | 682,244 | Common Stock |
Paula J. Swain | EVP, Human Resources | Sale of securities on an exchange or to another person at price $ 73.46 per share. | 01 Jan 2022 | 9,319 | 72,371 (0%) | 0% | 73.5 | 684,574 | Common Stock |
Paula J. Swain | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 9,319 | 10,870 | - | - | Non Qualfied Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 14,463 | 57,462 (0%) | 0% | 0 | Common Stock | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 8,678 | 67,292 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 8,678 | 38,417 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 28,926 | 133,823 (0%) | 0% | 0 | Common Stock | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 14,463 | 53,575 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 8,678 | 42,142 (0%) | 0% | 0 | Common Stock | |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 01 Jan 2022 | 3,615 | 31,046 (0%) | 0% | 0 | Common Stock | ||
Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 3,615 | 49,067 (0%) | 0% | 0 | Common Stock | |
Wendy L. Dixon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2021 | 20,000 | 0 | - | - | Non Qualfied Stock Option (right to buy) | |
Wendy L. Dixon | Director | Sale of securities on an exchange or to another person at price $ 22.05 per share. | 23 Dec 2021 | 20,000 | 17,259 (0%) | 0% | 22.1 | 441,000 | Common Stock |
Wendy L. Dixon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.25 per share. | 23 Dec 2021 | 20,000 | 37,259 (0%) | 0% | 73.3 | 1,465,000 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.40 per share. | 10 Dec 2021 | 533 | 33,464 (0%) | 0% | 65.4 | 34,858 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 61,338 (0%) | 0% | 0 | Common Stock | |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 63,693 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 40,644 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 42,999 (0%) | 0% | 0 | Common Stock | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 13,279 | 345,383 (0%) | 0% | 0 | Common Stock | |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,227 | 332,104 (0%) | 0% | 0 | Common Stock | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 58,614 (0%) | 0% | 0 | Common Stock | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 56,259 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 29,739 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 27,384 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 102,542 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 104,897 (0%) | 0% | 0 | Common Stock | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 39,112 (0%) | 0% | 0 | Common Stock | |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 36,757 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 31,642 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 33,997 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 68.67 per share. | 01 Oct 2021 | 389 | 31,263 (0%) | 0% | 68.7 | 26,713 | Common Stock |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 68.78 per share. | 30 Sep 2021 | 321 | 7,621 (0%) | 0% | 68.8 | 22,078 | Common Stock |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 68.78 per share. | 30 Sep 2021 | 244 | 17,259 (0%) | 0% | 68.8 | 16,782 | Common Stock |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 68.78 per share. | 30 Sep 2021 | 271 | 7,942 (0%) | 0% | 68.8 | 18,639 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 68.78 per share. | 30 Sep 2021 | 237 | 5,079 (0%) | 0% | 68.8 | 16,301 | Common Stock |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2021 | 1,255 | 1,255 (0%) | 0% | 0 | Common Stock | |
Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2021 | 5,910 | 5,910 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 382 | 1,912 | - | - | Incentive Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.36 per share. | 24 Sep 2021 | 382 | 36,187 (0%) | 0% | 65.4 | 24,968 | Common Stock |
Paula J. Swain | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 20 Sep 2021 | 1,356 | 60,959 (0%) | 0% | 73.2 | 99,273 | Common Stock |
Paula J. Swain | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2021 | 1,356 | 0 | - | - | Incentive Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 76.71 per share. | 01 Sep 2021 | 388 | 31,652 (0%) | 0% | 76.7 | 29,763 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 77.49 per share. | 02 Aug 2021 | 389 | 32,040 (0%) | 0% | 77.5 | 30,144 | Common Stock |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Sale of securities on an exchange or to another person at price $ 78.29 per share. | 29 Jul 2021 | 4,911 | 27,005 (0%) | 0% | 78.3 | 384,482 | Common Stock |
Paula J. Swain | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 273 | 59,603 (0%) | 0% | 83.3 | 22,752 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 61,866 (0%) | 0% | 0 | Common Stock | |
Paula J. Swain | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 1,990 | 59,876 (0%) | 0% | 83.6 | 166,324 | Common Stock |
Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 40,781 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jul 2021 | 516 | 40,265 (0%) | 0% | 0 | Common Stock | |
Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Herve Hoppenot | Director, Chairman / CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 16,089 | 331,439 (0%) | 0% | 83.6 | 1,344,719 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 84,851 | 84,851 | - | - | Employee Stock Option (right to buy) | |
Herve Hoppenot | Director, Chairman / CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 1,562 | 329,877 (0%) | 0% | 83.3 | 130,177 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 44,264 | 347,528 (0%) | 0% | 0 | Common Stock | |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 58,143 (0%) | 0% | 0 | Common Stock | |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 273 | 55,880 (0%) | 0% | 83.3 | 22,752 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 1,990 | 56,153 (0%) | 0% | 83.6 | 166,324 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 405 | 98,575 (0%) | 0% | 83.3 | 33,753 | Common Stock |
Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 101,933 (0%) | 0% | 0 | Common Stock | |
Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 2,953 | 98,980 (0%) | 0% | 83.6 | 246,812 | Common Stock |
Paul Trower | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 104 | 32,268 (0%) | 0% | 83.3 | 8,667 | Common Stock |
Paul Trower | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 3,250 | 3,250 | - | - | Employee Stock Option (right to buy) | |
Paul Trower | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 4,521 | 33,244 (0%) | 0% | 0 | Common Stock | |
Paul Trower | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 872 | 32,372 (0%) | 0% | 83.6 | 72,882 | Common Stock |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 1,990 | 32,317 (0%) | 0% | 83.6 | 166,324 | Common Stock |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 34,307 (0%) | 0% | 0 | Common Stock | |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 401 | 31,916 (0%) | 0% | 83.3 | 33,419 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 105,518 (0%) | 0% | 0 | Common Stock | |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 2,953 | 102,565 (0%) | 0% | 83.6 | 246,812 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 402 | 102,163 (0%) | 0% | 83.3 | 33,503 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 38,046 (0%) | 0% | 0 | Common Stock | |
Maria E. Pasquale | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 2,241 | 35,805 (0%) | 0% | 83.6 | 187,303 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 34,002 (0%) | 0% | 0 | Common Stock | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 1,573 | 32,429 (0%) | 0% | 83.6 | 131,471 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 84.09 per share. | 01 Jul 2021 | 396 | 26,149 (0%) | 0% | 84.1 | 33,300 | Common Stock |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 84.13 per share. | 30 Jun 2021 | 283 | 7,300 (0%) | 0% | 84.1 | 23,809 | Common Stock |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 84.13 per share. | 30 Jun 2021 | 214 | 17,015 (0%) | 0% | 84.1 | 18,004 | Common Stock |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 84.13 per share. | 30 Jun 2021 | 238 | 7,671 (0%) | 0% | 84.1 | 20,023 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 84.13 per share. | 30 Jun 2021 | 208 | 4,842 (0%) | 0% | 84.1 | 17,499 | Common Stock |
Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 85.37 per share. | 28 Jun 2021 | 27,194 | 94,080 (0%) | 0% | 85.4 | 2,321,552 | Common Stock |
Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.61 per share. | 28 Jun 2021 | 22,806 | 121,274 (0%) | 0% | 85.6 | 1,952,422 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.61 per share. | 28 Jun 2021 | 22,079 | 97,665 (0%) | 0% | 85.6 | 1,890,183 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2021 | 255 | 2,294 | - | - | Incentive Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.36 per share. | 18 Jun 2021 | 255 | 30,193 (0%) | 0% | 65.4 | 16,667 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 84.13 per share. | 01 Jun 2021 | 395 | 26,545 (0%) | 0% | 84.1 | 33,231 | Common Stock |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,923 | 16,801 (0%) | 0% | 0 | Common Stock | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 8,010 | 8,010 | - | - | Non-Qualified Stock Option (right to buy) | |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,923 | 7,433 (0%) | 0% | 0 | Common Stock | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,923 | 4,634 (0%) | 0% | 0 | Common Stock | |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 8,010 | 8,010 | - | - | Non-Qualified Stock Option (right to buy) | |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,923 | 3,344 (0%) | 0% | 0 | Common Stock | |
Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 8,010 | 8,010 | - | - | Non-Qualified Stock Option (right to buy) | |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 8,010 | 8,010 | - | - | Non-Qualified Stock Option (right to buy) | |
Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,923 | 10,844 (0%) | 0% | 0 | Common Stock | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 8,010 | 8,010 | - | - | Non-Qualified Stock Option (right to buy) | |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,923 | 7,017 (0%) | 0% | 0 | Common Stock | |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 8,010 | 8,010 | - | - | Non-Qualified Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 85.40 per share. | 03 May 2021 | 396 | 26,940 (0%) | 0% | 85.4 | 33,818 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 127 | 2,549 | - | - | Incentive Stock Option (right to buy) | |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.36 per share. | 23 Apr 2021 | 127 | 29,938 (0%) | 0% | 65.4 | 8,301 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.96 per share. | 09 Apr 2021 | 517 | 29,811 (0%) | 0% | 80.0 | 41,339 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.57 per share. | 01 Apr 2021 | 396 | 27,336 (0%) | 0% | 81.6 | 32,302 | Common Stock |
Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 81.27 per share. | 31 Mar 2021 | 298 | 5,094 (0%) | 0% | 81.3 | 24,218 | Common Stock |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 81.27 per share. | 31 Mar 2021 | 225 | 14,878 (0%) | 0% | 81.3 | 18,286 | Common Stock |
Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 81.27 per share. | 31 Mar 2021 | 251 | 5,510 (0%) | 0% | 81.3 | 20,399 | Common Stock |
Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 81.27 per share. | 31 Mar 2021 | 219 | 2,711 (0%) | 0% | 81.3 | 17,798 | Common Stock |
Michael James Morrissey | EVP, Head of Tech. Operations | Sale of securities on an exchange or to another person at price $ 81.08 per share. | 29 Mar 2021 | 20,000 | 45,452 (0%) | 0% | 81.1 | 1,621,600 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.36 per share. | 12 Mar 2021 | 128 | 30,328 (0%) | 0% | 65.4 | 8,366 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 128 | 2,676 | - | - | Incentive Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.73 per share. | 01 Mar 2021 | 395 | 27,732 (0%) | 0% | 79.7 | 31,493 | Common Stock |
Herve Hoppenot | Director, Chairman / CEO, President | Purchase of securities on an exchange or from another person at price $ 77.37 per share. | 23 Feb 2021 | 12,925 | 284,231 (0%) | 0% | 77.4 | 1,000,007 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.36 per share. | 16 Feb 2021 | 127 | 30,200 (0%) | 0% | 65.4 | 8,301 | Common Stock |
Maria E. Pasquale | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 127 | 2,804 | - | - | Incentive Stock Option (right to buy) | |
Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.99 per share. | 11 Feb 2021 | 1,210 | 32,611 (0%) | 0% | 85.0 | 102,838 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 01 Feb 2021 | 395 | 28,127 (0%) | 0% | 90 | 35,550 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 961 | 30,759 | - | - | Non-Qualified Stock Option (right to buy) | |
Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 01 Feb 2021 | 961 | 28,522 (0%) | 0% | 90 | 86,490 | Common Stock |
Dashyant Dhanak | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.42 per share. | 01 Feb 2021 | 961 | 29,483 (0%) | 0% | 65.4 | 62,869 | Common Stock |
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 2,744 | 49,994 (0%) | 0% | 100 | 274,400 | Common Stock |
Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 1,559 | 0 | - | - | Incentive Stock Option (right to buy) | |
Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 19,986 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 25 Jan 2021 | 19,986 | 163,770 (0%) | 0% | 73.2 | 1,463,175 | Common Stock |
Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 1,559 | 143,784 (0%) | 0% | 100 | 155,900 | Common Stock |
Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 25 Jan 2021 | 1,559 | 145,343 (0%) | 0% | 73.2 | 114,134 | Common Stock |
Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 19,986 | 143,784 (0%) | 0% | 100 | 1,998,600 | Common Stock |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 4,116 | 0 | - | - | Incentive Stock Option (right to buy) | |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Sale of securities on an exchange or to another person at price $ 99.00 per share. | 25 Jan 2021 | 4,116 | 27,158 (0%) | 0% | 99 | 407,484 | Common Stock |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.86 per share. | 25 Jan 2021 | 4,116 | 31,274 (0%) | 0% | 72.9 | 299,892 | Common Stock |
Vijay K. Iyengar | EVP GPS, BD, & Licensing | Sale of securities on an exchange or to another person at price $ 99.00 per share. | 25 Jan 2021 | 1,000 | 26,158 (0%) | 0% | 99 | 99,000 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 3,795 | 119,744 (0%) | 0% | 100 | 379,500 | Common Stock |
Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 3,795 | 8,539 | - | - | Non-Qualified Stock Option (right to buy) | |
Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 25 Jan 2021 | 3,795 | 123,539 (0%) | 0% | 68.6 | 260,413 | Common Stock |
Jonathan Elliott Dickinson | EVP, General Manager, Europe | 25 Jan 2021 | 78 | 27,135 (0%) | 0% | 100.5 | 7,839 | Common Stock | |
Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.50 per share. | 25 Jan 2021 | 78 | 65,452 (0%) | 0% | 100.5 | 7,839 | Common Stock |